- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/48 - Iso-indolesHydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Patent holdings for IPC class C07D 209/48
Total number of patents in this class: 767
10-year publication summary
|
61
|
65
|
55
|
50
|
45
|
38
|
33
|
37
|
29
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17786 |
19 |
| Amgen Inc. | 4323 |
12 |
| Cancer Research Technology Limited | 521 |
11 |
| FUJIFILM Corporation | 30155 |
10 |
| SHPP Global Technologies B.V. | 1094 |
9 |
| The Scripps Research Institute | 1344 |
8 |
| Siemens Medical Solutions USA, Inc. | 1484 |
7 |
| Wisconsin Alumni Research Foundation | 3931 |
7 |
| ExxonMobil Chemical Patents Inc. | 3865 |
7 |
| Arvinas Operations, Inc. | 250 |
7 |
| Boehringer Ingelheim International GmbH | 4569 |
6 |
| Syngenta Participations AG | 1612 |
6 |
| Astex Therapeutics Limited | 228 |
6 |
| SABIC Global Technologies B.V. | 4471 |
6 |
| The Trustees of Princeton University | 1234 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2966 |
6 |
| Vectus Biosystems Limited | 29 |
6 |
| Zeon Corporation | 4126 |
6 |
| Massachusetts Institute of Technology | 10201 |
5 |
| Celgene Corporation | 1392 |
5 |
| Other owners | 612 |